SILO
Silo Pharma·NASDAQ
--
--(--)
--
--(--)
SILO Filings
Filing Date
Form Description
Form Type
2026-03-27
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-27 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-23
Form 8-K - Current report
Key Events
2026-02-23 · Key Events
Form 8-K - Current report
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-29
Form 8-K - Current report
Key Events
2025-12-29 · Key Events
Form 8-K - Current report
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-28
Form EFFECT - Notice of Effectiveness
2025-11-28 ·
Form EFFECT - Notice of Effectiveness
2025-11-26
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-26 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-21
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-21 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
